The published refund policy has clear limits - the guarantee terms that override those limits (if any) are not documented in the publicly accessible policy pages reviewed for this article
What Research Shows So Far Retatrutide has been evaluated in phase 2 obesity and metabolic disease trials, with phase 3 results beginning to appear
If you plan to start retatrutide treatment, consult your healthcare professional first to discuss whether it is the right choice for you
Combined with mindful eating, exercise, adequate sleep, and avoiding sugary, ultra-processed foods, these strategies can help you maintain steady GLP-1 levels and support sustainable weight loss
While more research is needed, the safety profile of GLP-1 agonists in treating diabetes and obesity offers hope for their future use in addiction therapy
Compare that to semaglutide, which typically produces 15-17% weight loss at comparable timepoints